{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T13:20:45Z","timestamp":1762608045553,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672478","81772671","81972344"],"award-info":[{"award-number":["81672478","81772671","81972344"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7202020"],"award-info":[{"award-number":["7202020"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.exer.2020.108285","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:25:41Z","timestamp":1602203141000},"page":"108285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Macrophage polarization contributes to the efficacy of an oncolytic HSV-1 targeting human uveal melanoma in a murine xenograft model"],"prefix":"10.1016","volume":"202","author":[{"given":"Sisi","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guidong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingwei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fusheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2020.108285_bib1","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.2014.58.3377","article-title":"Talimogene laherparepvec improves durable response rate in patients with advanced melanoma","volume":"33","author":"Andtbacka","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.exer.2020.108285_bib2","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1128\/JVI.80.9.4501-4509.2006","article-title":"Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo","volume":"80","author":"Ank","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.exer.2020.108285_bib3","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41417-019-0091-0","article-title":"Safety and efficacy of oncolytic HSV-1 G207 inoculated into the cerebellum of mice","volume":"27","author":"Bernstock","year":"2020","journal-title":"Canc. Gene Ther."},{"key":"10.1016\/j.exer.2020.108285_bib4","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1167\/iovs.08-2874","article-title":"Infiltrating cells and IFNgamma production in the injected eye after uniocular anterior chamber inoculation of HSV-1","volume":"50","author":"Cathcart","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2020.108285_bib5","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1158\/0008-5472.CAN-17-0599","article-title":"Oncolytic virotherapy blockade by microglia and macrophages requires STAT1\/3","volume":"78","author":"Delwar","year":"2018","journal-title":"Canc. Res."},{"key":"10.1016\/j.exer.2020.108285_bib6","doi-asserted-by":"crossref","first-page":"E6157","DOI":"10.1073\/pnas.1700363114","article-title":"Stem cell-released oncolytic herpes simplex virus has therapeutic efficacy in brain metastatic melanomas","volume":"114","author":"Du","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exer.2020.108285_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0039-6257(88)90173-7","article-title":"Epidemiologic aspects of uveal melanoma","volume":"32","author":"Egan","year":"1988","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2020.108285_bib8","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.imbio.2013.06.003","article-title":"Tumor associated macrophages and neutrophils in cancer","volume":"218","author":"Galdiero","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.exer.2020.108285_bib9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1089\/hum.2018.107","article-title":"A phase 1 trial of oncolytic adenovirus ICOVIR-5 administered intravenously to cutaneous and uveal melanoma patients","volume":"30","author":"Garcia","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.exer.2020.108285_bib10","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/bjo.84.4.408","article-title":"Both CD4+ and CD8+ T cells are involved in protection against HSV-1 induced corneal scarring","volume":"84","author":"Ghiasi","year":"2000","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2020.108285_bib11","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1755-148X.2012.00971.x","article-title":"Genetic and molecular characterization of uveal melanoma cell lines","volume":"25","author":"Griewank","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.exer.2020.108285_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1755-148X.2012.00979.x","article-title":"The genetics of uveal melanoma: an emerging framework for targeted therapy","volume":"25","author":"Harbour","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.exer.2020.108285_bib13","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1586\/14737140.2015.1115725","article-title":"Clinical development of talimogene laherparepvec (T-VEC): a modified herpes simplex virus type-1-derived oncolytic immunotherapy","volume":"15","author":"Harrington","year":"2015","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.exer.2020.108285_bib14","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1136\/bjophthalmol-2011-301470","article-title":"Recombinant oncolytic adenovirus H101 combined with siBCL2: cytotoxic effect on uveal melanoma cell lines","volume":"96","author":"Huang","year":"2012","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2020.108285_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145342","article-title":"Novel markers to delineate murine M1 and M2 macrophages","volume":"10","author":"Jablonski","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.exer.2020.108285_bib16","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1001\/jamaophthalmol.2018.1813","article-title":"Continued poor survival in metastatic uveal melanoma: implications for molecular prognostication, surveillance imaging, adjuvant therapy, and clinical trials","volume":"136","author":"Johnson","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.exer.2020.108285_bib17","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1245\/s10434-009-0809-6","article-title":"Local and distant immunity induced by intralesional vaccination with an oncolytic herpes virus encoding GM-CSF in patients with stage IIIc and IV melanoma","volume":"17","author":"Kaufman","year":"2010","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.exer.2020.108285_bib18","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrd4663","article-title":"Oncolytic viruses: a new class of immunotherapy drugs","volume":"14","author":"Kaufman","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.exer.2020.108285_bib19","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nrd.2016.178","article-title":"Oncolytic viruses: a new class of immunotherapy drugs","volume":"15","author":"Kaufman","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.exer.2020.108285_bib20","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1096\/fasebj.13.11.1325","article-title":"Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207)","volume":"13","author":"Kooby","year":"1999","journal-title":"Faseb. J."},{"key":"10.1016\/j.exer.2020.108285_bib21","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/S0161-6420(98)91121-6","article-title":"A comparison of cause-specific melanoma mortality and all-cause mortality in survival analyses after radiation treatment for uveal melanoma","volume":"105","author":"Kroll","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2020.108285_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00578-17","article-title":"Roles of M1 and M2 macrophages in herpes simplex virus 1 infectivity","volume":"91","author":"Lee","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.exer.2020.108285_bib23","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/sj.gt.3301885","article-title":"ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties","volume":"10","author":"Liu","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.exer.2020.108285_bib24","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.exer.2018.04.009","article-title":"Antitumor efficacy of VP22-CD\/5-FC suicide gene system mediated by lentivirus in a murine uveal melanoma model","volume":"172","author":"Liu","year":"2018","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2020.108285_bib25","doi-asserted-by":"crossref","first-page":"2359s","DOI":"10.1158\/1078-0432.CCR-05-2537","article-title":"Immunosuppression in melanoma immunotherapy: potential opportunities for intervention","volume":"12","author":"Lizee","year":"2006","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.exer.2020.108285_bib26","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0002-9440(10)65173-5","article-title":"Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry","volume":"155","author":"Maniotis","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exer.2020.108285_bib27","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/00006123-199304000-00016","article-title":"Reduction and elimination of encephalitis in an experimental glioma therapy model with attenuated herpes simplex mutants that retain susceptibility to acyclovir","volume":"32","author":"Markert","year":"1993","journal-title":"Neurosurgery"},{"key":"10.1016\/j.exer.2020.108285_bib28","doi-asserted-by":"crossref","first-page":"17253","DOI":"10.1073\/pnas.1308887110","article-title":"Modulation of macrophage phenotype by cell shape","volume":"110","author":"McWhorter","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exer.2020.108285_bib29","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/1097-0142(194905)2:3<516::AID-CNCR2820020316>3.0.CO;2-P","article-title":"Effect of inoculation of the viruses of influenza A and herpes simplex on the growth of transplantable tumors in mice","volume":"2","author":"Moore","year":"1949","journal-title":"Cancer"},{"key":"10.1016\/j.exer.2020.108285_bib30","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.exer.2020.108285_bib31","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1006\/mthe.2001.0303","article-title":"Therapeutic efficacy of G207, a conditionally replicating herpes simplex virus type 1 mutant, for gallbladder carcinoma in immunocompetent hamsters","volume":"3","author":"Nakano","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.exer.2020.108285_bib32","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.3389\/fimmu.2019.02674","article-title":"Macrophage coordination of the interferon lambda immune response","volume":"10","author":"Read","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.exer.2020.108285_bib33","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nm.4098","article-title":"Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status","volume":"22","author":"Schoumacher","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.exer.2020.108285_bib34","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0161-6420(90)32512-5","article-title":"Relative survival rates after alternative therapies for uveal melanoma","volume":"97","author":"Seddon","year":"1990","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2020.108285_bib35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ohc.2004.07.002","article-title":"Uveal melanoma: epidemiologic aspects","volume":"18","author":"Singh","year":"2005","journal-title":"Ophthalmol Clin North Am"},{"key":"10.1016\/j.exer.2020.108285_bib36","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","article-title":"Uveal melanoma: trends in incidence, treatment, and survival","volume":"118","author":"Singh","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2020.108285_bib37","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jid.2015.12.022","article-title":"IFN-gamma primes keratinocytes for HSV-1-Induced inflammasome activation","volume":"136","author":"Strittmatter","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.exer.2020.108285_bib38","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1128\/JVI.72.3.2560-2563.1998","article-title":"Herpes simplex virus type 2 ICP47 inhibits human TAP but not mouse TAP","volume":"72","author":"Tomazin","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.exer.2020.108285_bib39","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1182\/blood-2011-11-370130","article-title":"Regulation of dendritic cell development by GM-CSF: molecular control and implications for immune homeostasis and therapy","volume":"119","author":"van de Laar","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exer.2020.108285_bib40","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.imbio.2014.05.002","article-title":"Human macrophage polarization in vitro: maturation and activation methods compared","volume":"219","author":"Vogel","year":"2014","journal-title":"Immunobiology"},{"key":"10.1016\/j.exer.2020.108285_bib41","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/imm.12337","article-title":"Both plasmacytoid dendritic cells and monocytes stimulate natural killer cells early during human herpes simplex virus type 1 infections","volume":"143","author":"Vogel","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.exer.2020.108285_bib42","doi-asserted-by":"crossref","first-page":"226ra232","DOI":"10.1126\/scitranslmed.3008095","article-title":"Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy","volume":"6","author":"Zamarin","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.exer.2020.108285_bib43","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.cellsig.2013.11.004","article-title":"Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways","volume":"26","author":"Zhou","year":"2014","journal-title":"Cell. Signal."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483520305431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483520305431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:31:56Z","timestamp":1762147916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483520305431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":43,"alternative-id":["S0014483520305431"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2020.108285","relation":{},"ISSN":["0014-4835"],"issn-type":[{"type":"print","value":"0014-4835"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Macrophage polarization contributes to the efficacy of an oncolytic HSV-1 targeting human uveal melanoma in a murine xenograft model","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2020.108285","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108285"}}